Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,277,200 | 218,500 | 1,727,600 | 1,748,100 | 1,430,100 |
| Depreciation Amortization | 277,900 | 143,100 | 1,117,000 | 982,300 | 805,700 |
| Income taxes - deferred | -47,500 | 1,000 | -426,800 | -750,100 | -622,800 |
| Accounts receivable | -67,300 | -87,500 | 324,800 | 157,800 | 211,500 |
| Other Working Capital | 99,900 | -780,500 | -145,500 | -221,700 | -105,200 |
| Other Operating Activity | -641,900 | 667,200 | 1,042,800 | 885,200 | 277,000 |
| Operating Cash Flow | $898,300 | $161,800 | $3,639,900 | $2,801,600 | $1,996,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -94,800 | -57,900 | -258,100 | -206,500 | -164,500 |
| Net Acquisitions | N/A | N/A | 28,100 | 28,100 | 28,100 |
| Purchase Of Investment | -2,311,600 | -1,133,500 | -3,808,700 | -2,372,600 | -1,626,900 |
| Sale Of Investment | 1,461,500 | 543,600 | 3,498,900 | 2,119,300 | 1,543,900 |
| Purchase Sale Intangibles | -1,900 | 0 | -18,800 | -19,900 | 0 |
| Other Investing Activity | 990,400 | -200 | -23,900 | -19,300 | 2,000 |
| Investing Cash Flow | $45,500 | $-648,000 | $-563,700 | $-451,000 | $-217,400 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -170,000 | -170,000 | -170,000 |
| Common Stock Issued | -11,500 | N/A | N/A | -8,300 | -14,200 |
| Common Stock Repurchased | -500,000 | -20,800 | -1,800,000 | -1,800,000 | -1,050,000 |
| Other Financing Activity | 23,500 | 4,300 | -116,200 | -117,700 | -115,300 |
| Financing Cash Flow | $-488,000 | $-16,500 | $-2,086,200 | $-2,096,000 | $-1,349,500 |
| Exchange Rate Effect | -70,600 | -9,400 | -59,800 | -44,000 | -18,600 |
| Beginning Cash Position | 2,261,400 | 2,261,400 | 1,331,200 | 1,331,200 | 1,331,200 |
| End Cash Position | 2,646,600 | 1,749,300 | 2,261,400 | 1,541,800 | 1,742,000 |
| Net Cash Flow | $385,200 | $-512,100 | $930,200 | $210,600 | $410,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 898,300 | 161,800 | 3,639,900 | 2,801,600 | 1,996,300 |
| Capital Expenditure | -94,800 | -57,900 | -258,100 | -206,500 | -164,500 |
| Free Cash Flow | 803,500 | 103,900 | 3,381,800 | 2,595,100 | 1,831,800 |